Therapeutics: DNA (cytosine-5-)-methyltransferase 3β (DNMT3B)

Cancer

INDICATION: Melanoma

Patient sample, cell culture and mouse studies suggest inhibiting DNMT3B could

Read the full 124 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE